Barber shop quartet

The biotech IPO window isn't slamming shut, but companies going out will need to leave money on the table to incent investors with lower deal prices. Bankers are telling their companies to take a closer look at how they plan to use IPO proceeds, in expectation of reduced working capital.

Some bankers think it might be better to take a pause this quarter and see what January brings...